Article
Pharmaceutical Executive
From Many, One
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Paul Hudson: A Mindset for Miracles
Pharmaceutical Executive Daily: September 17, 2025
FDA Sends Warning Letters to Novo Nordisk, Eli Lilly, and Hims Regarding Misleading Pharmaceutical Advertising
Pharmaceutical Executive Daily: September 16, 2025
Lilly’s Orforglipron Outperforms Oral Semaglutide in Head-To-Head Trial
Eli Lilly to Construct $5 Billion Manufacturing Plant in Virginia, Expanding US Biopharma Capacity